Hudson TechBio Consulting Limited 14112951 true 2025-02-01 2025-12-31 2025-12-31 The principal activity of the company is that of management consultancy activities other than financial management. Digita Accounts Production Advanced 6.30.9574.0 true Mr Alexander Hudson 14112951 2025-02-01 2025-12-31 14112951 2025-12-31 14112951 bus:OrdinaryShareClass1 2025-12-31 14112951 core:RetainedEarningsAccumulatedLosses 2025-12-31 14112951 core:ShareCapital 2025-12-31 14112951 core:CurrentFinancialInstruments 2025-12-31 14112951 core:CurrentFinancialInstruments core:WithinOneYear 2025-12-31 14112951 bus:FRS102 2025-02-01 2025-12-31 14112951 bus:AuditExempt-NoAccountantsReport 2025-02-01 2025-12-31 14112951 bus:FullAccounts 2025-02-01 2025-12-31 14112951 bus:RegisteredOffice 2025-02-01 2025-12-31 14112951 bus:Director1 2025-02-01 2025-12-31 14112951 bus:OrdinaryShareClass1 2025-02-01 2025-12-31 14112951 bus:EntityNoLongerTradingButTradedInPast 2025-02-01 2025-12-31 14112951 bus:PrivateLimitedCompanyLtd 2025-02-01 2025-12-31 14112951 countries:England 2025-02-01 2025-12-31 14112951 2025-01-31 14112951 bus:OrdinaryShareClass1 2025-01-31 14112951 core:RetainedEarningsAccumulatedLosses 2025-01-31 14112951 core:ShareCapital 2025-01-31 14112951 core:CurrentFinancialInstruments 2025-01-31 14112951 core:CurrentFinancialInstruments core:WithinOneYear 2025-01-31 iso4217:GBP xbrli:pure xbrli:shares

Registration number: 14112951

Hudson TechBio Consulting Limited

Unaudited Filleted Financial Statements

for the Period from 1 February 2025 to 31 December 2025

 

Hudson TechBio Consulting Limited

(Registration number: 14112951)
Balance Sheet as at 31 December 2025

Note

31 December 2025
£

31 January 2025
£

Current assets

 

Debtors

3

100

913

Creditors: Amounts falling due within one year

-

(913)

Net assets

 

100

-

Capital and reserves

 

Called up share capital

4

100

100

Retained earnings

-

(100)

Shareholders' funds

 

100

-

For the financial period ending 31 December 2025 the company was entitled to exemption from audit under section 480 of the Companies Act 2006 relating to dormant companies.

Director's responsibilities:

The members have not required the company to obtain an audit of its accounts for the period in question in accordance with section 476; and

The director acknowledges his responsibilities for complying with the requirements of the Act with respect to accounting records and the preparation of accounts.

These financial statements have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies regime. As permitted by section 444 (5A) of the Companies Act 2006, the director has not delivered to the registrar a copy of the Profit and Loss Account.

Approved and authorised by the director on 17 June 2026
 

.........................................
Mr Alexander Hudson
Director

 

Hudson TechBio Consulting Limited

Notes to the Unaudited Financial Statements for the Period from 1 February 2025 to 31 December 2025

1

General information

The company is a private company limited by share capital, incorporated in England.

The address of its registered office is:
53 Cumberland Road
Oxford
Oxfordshire
OX4 2BZ

These financial statements were authorised for issue by the director on 17 June 2026.

2

Accounting policies

Summary of significant accounting policies and key accounting estimates

The principal accounting policies applied in the preparation of these financial statements are set out below. These policies have been consistently applied to all the years presented, unless otherwise stated.

Statement of compliance

These financial statements have been prepared in accordance with Financial Reporting Standard 102 Section 1A smaller entities - 'The Financial Reporting Standard applicable in the United Kingdom and Republic of Ireland' and the Companies Act 2006 (as applicable to companies subject to the small companies' regime).

Basis of preparation

These financial statements have been prepared using the historical cost convention except that as disclosed in the accounting policies certain items are shown at fair value.

Tangible assets

Tangible assets are stated in the balance sheet at cost, less any subsequent accumulated depreciation and subsequent accumulated impairment losses.

The cost of tangible assets includes directly attributable incremental costs incurred in their acquisition and installation.

Depreciation

Depreciation is charged so as to write off the cost of assets, other than land and properties under construction over their estimated useful lives, as follows:

Trade debtors

Trade debtors are amounts due from customers for merchandise sold or services performed in the ordinary course of business.

Trade debtors are recognised initially at the transaction price. They are subsequently measured at amortised cost using the effective interest method, less provision for impairment. A provision for the impairment of trade debtors is established when there is objective evidence that the company will not be able to collect all amounts due according to the original terms of the receivables.

 

Hudson TechBio Consulting Limited

Notes to the Unaudited Financial Statements for the Period from 1 February 2025 to 31 December 2025

Share capital

Ordinary shares are classified as equity. Equity instruments are measured at the fair value of the cash or other resources received or receivable, net of the direct costs of issuing the equity instruments. If payment is deferred and the time value of money is material, the initial measurement is on a present value basis.

3

Debtors

Current

31 December 2025
£

31 January 2025
£

Other debtors

100

913

 

100

913

4

Share capital

Allotted, called up and fully paid shares

31 December 2025

31 January 2025

No.

£

No.

£

Ordinary of £1 each

100

100

100

100